| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2003 | EP0904097B1 Combinations of vasopressin and adrenergic agents for the treatment of cardiac arrest |
| 05/28/2003 | EP0888352B1 Fused imidazole derivatives as multidrug resistance modulators |
| 05/28/2003 | EP0874814B1 25-hydroxy-16-ene-26,27-bishomo-cholecalciferols |
| 05/28/2003 | EP0869781B1 Transdermal device for the delivery of flurbiprofen |
| 05/28/2003 | EP0859612B1 Pharmaceutical composition containing an acid-labile omeprazole and process for its preparation |
| 05/28/2003 | EP0859592B1 Skin-care agent for ageing skin |
| 05/28/2003 | EP0850222B1 Piperazine derivatives and process for the preparation thereof |
| 05/28/2003 | EP0822819B1 Solvent detergent emulsions having antiviral activity |
| 05/28/2003 | EP0817784B1 Process for the synthesis of nucleoside analogues |
| 05/28/2003 | EP0814792B1 Mercapto and seleno derivatives as inhibitors of nitric oxide synthase |
| 05/28/2003 | EP0814789B1 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 05/28/2003 | EP0788360B1 Boronic ester and acid compounds, synthesis and uses |
| 05/28/2003 | EP0786995B1 Use of 5-(tetradecyloxy)-2-furan carboxylic acid for treating alzheimer's disease or psychosis |
| 05/28/2003 | EP0783314B1 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards |
| 05/28/2003 | EP0717626B1 Preparation for substitution therapy, containing at least one progestogen and at least one extrogen |
| 05/28/2003 | EP0690715B1 Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 05/28/2003 | EP0668759B1 Transdermal delivery of ketorolac |
| 05/28/2003 | EP0625904B1 Bimodal molecular weight hyaluronate formulations and methods for using same |
| 05/28/2003 | CN1420891A Pharmaceutical compound |
| 05/28/2003 | CN1420890A Tricyclic imidazopyridines |
| 05/28/2003 | CN1420889A Pharmaceutically active isoindoline derivs. |
| 05/28/2003 | CN1420888A Substd. pyrazoloÒÇö4,3-eÒÇòdiazepines, pharmaceu-tical compositions contg. them, use as medicinal products and processes for preparing them |
| 05/28/2003 | CN1420887A 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors |
| 05/28/2003 | CN1420886A (5R)-(methylamino)-5,6-dihydro-4H-imidazo ÒÇö4,5,1-ijÒÇòquinoline-2 (1H)-thione |
| 05/28/2003 | CN1420885A Therapeutically useful new salts of CCK inhibitors, process for preparation thereof and pharmaceutical preparations contg. them |
| 05/28/2003 | CN1420884A 2-substd. 4-heteroaryl-pyrimidines and their use in treatment of proliferative disorders |
| 05/28/2003 | CN1420883A N-aryl-(homopiperazinyl) cyclohexyl amines as 5-HT transporters |
| 05/28/2003 | CN1420882A Substd. oxoazaheterocyclyl compounds |
| 05/28/2003 | CN1420881A Beta-amino acid derivs. as inhibitors of matrix metalloproteases and TNF-alpha |
| 05/28/2003 | CN1420880A Substd. N-Benzyl-indol-3-yl glyoxylic acid derivs. having anti-tumoral effect |
| 05/28/2003 | CN1420879A Substd. pyridines and pyridazines with angiogenesis inhibiting activity |
| 05/28/2003 | CN1420878A Compound with growth hormone releasing properties |
| 05/28/2003 | CN1420872A Caspase inhibitors and use thereof |
| 05/28/2003 | CN1420870A Modulators of dopamine neurotransmission |
| 05/28/2003 | CN1420869A Modulators of dopamine neurotransmission |
| 05/28/2003 | CN1420868A Process for preparation of benzamide deriv. of formula (1) and its salts |
| 05/28/2003 | CN1420865A Ocular hypotensive lipids |
| 05/28/2003 | CN1420843A Method for preparing orthosilicic acid, orthosilicic acid as obtained, and its use |
| 05/28/2003 | CN1420797A Method for improvement of islet signaling in diabetes mellitus and for its prevention |
| 05/28/2003 | CN1420788A Improved treatment of neovascularization |
| 05/28/2003 | CN1420787A Magnetic targeted carrier composed of iron and porous materials for targeted delivery of biologically active agents |
| 05/28/2003 | CN1420786A Treatment of fungal infections with beta glucan synthase inhibitor antifungals combined with anti HSP90 antibodies |
| 05/28/2003 | CN1420785A Method of treating cancer with anti-neurotrophin agents |
| 05/28/2003 | CN1420780A Pharmaceutical compositions including alginates |
| 05/28/2003 | CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base |
| 05/28/2003 | CN1420777A Pharmaceutical compositions and preparations for treatment of metabolic bone disease |
| 05/28/2003 | CN1420776A Inhibition of cyclooxygenase-2 activity |
| 05/28/2003 | CN1420775A Method for identifying and using A2B adenosine receptor antagonists to mediate mammalian cell proliferation |
| 05/28/2003 | CN1420774A Sustained release beadlets conty. stavudine |
| 05/28/2003 | CN1420772A Prophylactic and therapeutic use of oltipraz as antifibrotic and anticirrhotic agent in liver and pharmaceutical composition contg. oltipraz |
| 05/28/2003 | CN1420771A Hydrophilic molecular disperse solutions of carvedilol |
| 05/28/2003 | CN1420770A Method of delivery of cetyl myristoleate |
| 05/28/2003 | CN1420769A Method of treating osteoarthritis with inducible nitric oxide synthase inhibitors |
| 05/28/2003 | CN1420768A Combination product comprising non-steroidal antiandrogen and EGFR tyrosine kinase inhibitor |
| 05/28/2003 | CN1420767A Pharmaceutical formulation contg. tolterodine and its use |
| 05/28/2003 | CN1420766A Partial fatty acid oxidation inhibitors in treatment of congestive heart failure |
| 05/28/2003 | CN1420765A Method for chemoprevention of prostate cancer |
| 05/28/2003 | CN1420764A Pharmaceutical preparations and their manufacture |
| 05/28/2003 | CN1420763A Orally administered controlled delivery system for once daily administration of ciprofloxacin |
| 05/28/2003 | CN1420762A Devices for delivery of drugs having antiprogestinic properties |
| 05/28/2003 | CN1420761A Composition for inhalation comprising delta-9-tetrahydrocannabinol in semiaqueous solvent |
| 05/28/2003 | CN1420755A Method and composition for treatment of scars |
| 05/28/2003 | CN1420723A Compositions and methods for L-nucleosides, and their analogs |
| 05/28/2003 | CN1420120A Medicinal preparation contg. 1-N-ethyl vistamycin or its salt, and process for preparing same |
| 05/28/2003 | CN1420114A 2,3-disubstd. -4(3H)-quinazolones |
| 05/28/2003 | CN1420111A Naphthalene alizarin derivatives, preparing method and use thereof |
| 05/28/2003 | CN1419940A Medical ointment, film and tincture |
| 05/28/2003 | CN1419919A 'Acne and rosacca aqueous powder' and 'acne and rosacca capsule' as medicine for treating acne and rosacca |
| 05/28/2003 | CN1419914A Mild purgative |
| 05/28/2003 | CN1419913A Oral cavity disintegrating tablet of erythromycin ethylsuccinate for treating infection, and preparing method thereof |
| 05/28/2003 | CN1419912A Cyanidenon, apigenin -7-0-beta-D-glucoside use and related medicine |
| 05/28/2003 | CN1419911A Sucros ester-C20-28 alcohol preparation |
| 05/28/2003 | CN1419910A Oral cavity disintegrating tablet of chlorphenamine for treating allergy, and preparing method thereof |
| 05/28/2003 | CN1419909A Oral cavity disintegrating tablet of diclofenac for treating inflammation and pain, and preparing method thereof |
| 05/28/2003 | CN1419908A Oral cavity disintegrating tablet of clenbuterol hydrochloride for treating asthma, and preparing method thereof |
| 05/28/2003 | CN1109749C Pressure-mediated intracellular delivery of molecules or microparticles |
| 05/28/2003 | CN1109741C Soap bars with bactericidal capacity and methods of enhancing such capacity |
| 05/28/2003 | CN1109689C 14 alpha, 17 alpha-C2-bridged 19-nor-progesterone derivatives |
| 05/28/2003 | CN1109688C Preparation and use of tazobactam semihydrate |
| 05/28/2003 | CN1109687C Macrolides with antitumor activity, method for preparing same and use thereof |
| 05/28/2003 | CN1109686C Acronycine compounds and pharmaceutical compositions contg. them |
| 05/28/2003 | CN1109685C Substd. benzocycloheptapyridine derivs. useful for inhibition of farnesyl protein transferase |
| 05/28/2003 | CN1109684C Novel compound form |
| 05/28/2003 | CN1109683C 2-arylbenzo [b] thiophenes useful for treatment of estrogen deprivation syndrome |
| 05/28/2003 | CN1109681C Flavone chromium, its producing method and use thereof |
| 05/28/2003 | CN1109680C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/28/2003 | CN1109679C Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 05/28/2003 | CN1109678C Annona tactone analogue and its use |
| 05/28/2003 | CN1109677C Monohydrates of aminobenzenesulfonic acid derivs. and method for preparing same |
| 05/28/2003 | CN1109675C Arylpyrimidine derivs. |
| 05/28/2003 | CN1109674C Imidazole deriv. and process for preparing same |
| 05/28/2003 | CN1109555C Medicine for treating fracture and traumatic injury, and preparing method thereof |
| 05/28/2003 | CN1109552C Enteritis curing capsule |
| 05/28/2003 | CN1109551C Medicine for treating cancer and process for preparing same |
| 05/28/2003 | CN1109547C Antithrombotic and antiatherogenic pharmaceutical composition including thienopyridine deriv. and HMG-CoA reductase inhibitor |
| 05/28/2003 | CN1109546C Compound antimalarial medicine contg. artemisinins medicines and malaridine |
| 05/28/2003 | CN1109545C Formulation for iron chelation and process for preparing same |
| 05/28/2003 | CN1109544C Beta-alkoxyacrylates against malaria |
| 05/28/2003 | CN1109543C Pharmaceutical prepn. comprising eicosapentaenoic acid and/or stearidonic acid |
| 05/28/2003 | CN1109542C Improved nicotine lozenge and therapeutic method for smoking cessation |